Welcome to the e-CCO Library!

P009: Disease classifier and microbial dysbiosis index tools cross-predict various pathogenic conditions due to general microbial signal
Year: 2021
Source: ECCO'21 Virtual
Authors: Abbas Egbariya, H.(1);Braun, T.(2);Hadar , R.(2);Gal-Mor, O.(1);Shental, N.(3);Haberman, Y.(4);Amir, A.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P009: Fluorescence mediated tomography detects and quantifies early intestinal neutrophil infiltration in experimental colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. M. Nowacki*1,2, P. Lenz3, D. Bettenworth2, M. Brückner2, P. Tepasse2, A. Becker4, M. Wildgruber4, M. Eisenblätter4

Created: Friday, 22 February 2019, 9:41 AM
P009: IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ullrich, K.(1)*;Derdau, J.(1);Baltes, C.(2);Rosso, G.(3);Uderhardt, S.(4);Schulze, L.L.(1);Liu, L.J.(1);Dedden, M.(1);Spocinska, M.(1);Kainka, L.(2);Kubánková, M.(3);Müller, T.M.(1);Schmidt, N.M.(1);Becker, E.(1);Atreya, I.(1);Neurath-Finotto, S.(5);Prots, I.(6);Weigmann, B.(1);López-Posadas, R.(1);Atreya, R.(1);Ekici, A.B.(7);Lautenschläger, F.(8);Guck, J.(3);Neurath, M.F.(1);Zundler, S.(1);
Created: Friday, 14 July 2023, 10:43 AM
P009: Integrin-b7+ cytotoxic MAIT cells are expanded in the colon of Ulcerative Colitis patients, correlate with disease severity and are targeted by vedolizumab therapy.
Year: 2022
Source: ECCO'22
Authors: Hermangild Kottoor, S.(1);ibraheim, H.(1);Polychronis, P.(2);Senthuran, B.(2);Jameson, E.(2);Samaan, M.(2);Irving, P.(2);Powell, N.(1);
Created: Friday, 11 February 2022, 3:52 PM
P009: Lipid biomarkers to diagnose Crohn’s disease using metabonomic profiling approach in serum and faeces.
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

N. S. Ding*1, 2, M. Sarafian1, 2, R. Misra1, P. Hendy1, L. Penez1, E. Holmes2, A. Hart1

Created: Friday, 22 February 2019, 9:49 AM
P010 Measurement of colonic mucosal content of biologics with the use of magnetic resonance imaging (MRI): A pilot study in patients with ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Filip1, P. Bar2, D. Bartusik-Aebisher3, D. Aebisher3

Created: Thursday, 30 January 2020, 10:12 AM
P0100: Intestinal adaptation in a mouse model of Crohn’s- like ileitis under short bowel conditions
Year: 2025
Source: ECCO'25
Authors: Jadzewskix7x7x7 E.(1)*;Reinerx7x7x7 J.(2);Lamprechtx7x7x7 G.(2);Wittex7x7x7 M.(3);Berlinx7x7x7 P.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0101: Phenotyping of human UC colonic tissue reveals inflammatory pathway gene expression in PD-1+ conventional and regulatory T cells which overlap with those regulated by rosnilimab in a mouse model of colitis
Year: 2025
Source: ECCO'25
Authors: Linggix7x7x7 B.(1)*;Hainesx7x7x7 C.(2);Renx7x7x7 Y.(1);Parmleyx7x7x7 S.(2);Dahlx7x7x7 M.(2);Kwonx7x7x7 J.(3);Sorooshx7x7x7 P.(2);Lizzulx7x7x7 P.(4);Sibleyx7x7x7 C.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0102: Isatin: An indole alkaloid with intestinal anti-inflammatory activity in the trinitrobenzene sulfonic acid colitis model
Year: 2025
Source: ECCO'25
Authors: Soccax7x7x7 E.A.R.(1);de Almeidax7x7x7 A.C.A.(2);Dunderx7x7x7 R.J.(1);Manzox7x7x7 L.P.(1);de-Fariax7x7x7 F.M.(3);Souza-Britox7x7x7 A.R.M.(1);Luiz-Ferreirax7x7x7 A.(4)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0103: Systems biology analysis of cytokine signalling in IBD highlights the importance of TYK2-dependent pathways
Year: 2025
Source: ECCO'25
Authors: Deschx7x7x7 N.(1)*;Petrakisx7x7x7 I.(1);Singhx7x7x7 N.(1);Tangx7x7x7 J.(1);Sirota-Madix7x7x7 A.(2);Schusterx7x7x7 R.(2);Davidzohnx7x7x7 N.(2);Wyrobnikx7x7x7 I.(2);Shen-Orrx7x7x7 S.S.(2x7x7x73);Chowersx7x7x7 Y.(2);Panchalx7x7x7 P.(1);Wennbox7x7x7 H.(1);Thakkerx7x7x7 P.(1);Arunachalamx7x7x7 V.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0104: Decoding cytokine networks in ulcerative colitis to identify pathogenic mechanisms and therapeutic targets
Year: 2025
Source: ECCO'25
Authors: Olbeix7x7x7 M.(1)*;Hautefortx7x7x7 I.(1x7x7x72x7x7x73x7x7x74);Thomasx7x7x7 J.P.(1x7x7x75);Csabaix7x7x7 L.(6);Boharx7x7x7 B.(1);Ibraheimx7x7x7 H.(1);Saifuddinx7x7x7 A.(1);Modosx7x7x7 D.(1x7x7x73);Powellx7x7x7 N.(1);Korcsmarosx7x7x7 T.(1x7x7x72x7x7x73x7x7x74);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0105: Evaluation of Stimuli Driving Oncostatin M Expression in Bone Marrow-Derived Macrophages
Year: 2025
Source: ECCO'25
Authors: Velasco Blázquezx7x7x7 L.(1x7x7x72)*;Cancinox7x7x7 C.(1x7x7x72);Luox7x7x7 Y.(1x7x7x72);Konopkax7x7x7 A.(1x7x7x72);Hegazyx7x7x7 A.N.(1x7x7x72);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0106: Profiling inflammation-associated T helper subsets in Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Jiangx7x7x7 Q.(1)*;Lindelaufx7x7x7 C.(1);Ouboterx7x7x7 L.F.(2);Koningx7x7x7 F.(1);van der Meulen-de Jongx7x7x7 A.E.(2);van Unenx7x7x7 V.(1);Pascuttix7x7x7 M.F.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0107: Conceptualising avoidable inflammatory bowel disease admissions from the perspective of clinicians: An international mixed methods study
Year: 2025
Source: ECCO'25
Authors: Hawkinsx7x7x7 R.(1)*;Hindx7x7x7 D.(1);Matthewx7x7x7 L.(2);Lobox7x7x7 A.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0108: Exploring Microbiota-Immune Interactions in Short Bowel Syndrome and Crohn’s Disease in a model of human microbiota associated mice
Year: 2025
Source: ECCO'25
Authors: Masi x7x7x7 L.(1);Petito x7x7x7 V.(1);Troisi x7x7x7 S.(1x7x7x72);Emoli x7x7x7 V.(1);Deleu x7x7x7 S.(1x7x7x73x7x7x74);Becherucci x7x7x7 G.(1);Migliore x7x7x7 G.(1);Pane x7x7x7 C.(1x7x7x72)*;Carlà x7x7x7 A.S.(1);Foscarini x7x7x7 E.(1);Profeta x7x7x7 F.(1);Chieppa x7x7x7 M.(5);Mocci x7x7x7 G.(6);Lopetuso x7x7x7 L.R.(2x7x7x77x7x7x78);Gasbarrini x7x7x7 A.(1x7x7x73x7x7x77);Papa x7x7x7 A.(3x7x7x77);Scaldaferri x7x7x7 F.(1x7x7x73x7x7x77);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0109: SEMA3B is related to anti-TNF therapy response in Ulcerative Colitis patients but shows no relevant outcomes in modulating intestinal inflammation in vivo.
Year: 2025
Source: ECCO'25
Authors: Arosa Garcíax7x7x7 L.(1)*;Malvar-Fernándezx7x7x7 B.(2);Garcíax7x7x7 S.(2);Conde-Arandax7x7x7 J.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P010: Adherent-Invasive Escherichia Coli strain O83:H1 induces inflammatory response in Crohn's disease
Year: 2022
Source: ECCO'22
Authors: Iaquinto, G.C.(1);Mazzarella, G.(2);Rotondi Aufiero, V.(3);
Created: Friday, 11 February 2022, 3:52 PM
P010: Effects of cigarette smoke on the DSS-induced colitis model in C57Bl/6 mice
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Phillips B.1, Lo Sasso G.*2, Talikka M.2, Veljkovic E.1, Martin F.2, Elamin A.2, Guedj E.2, Ivanov N.2, Peitsch M.2, Hoeng J.2

Created: Wednesday, 20 February 2019, 10:36 AM
P010: GSDMB-mediated pyroptosis exacerbates intestinal inflammation by destroying intestinal epithelium in Crohn’s disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Gong, W.(1);Liu, P.(2);Ren, J.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P010: Infliximab skews macrophages towards an IL10-high/IL12p40-low phenotype in an Fc region dependent manner
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

F. Bloemendaal*1, M. Wildenberg1, A. Levin1, P. Koelink1, A.C. Vos2, G. D’Haens1, G. van den Brink1

Created: Friday, 22 February 2019, 9:49 AM